The 2021 World Health Organization (WHO) classification has updated the definition of grade 2 gliomas and the presence of isocitrate dehydrogenase (IDH) mutation has been deemed the cornerstone of diagnosis. Though slow-growing and having a low proliferative index, grade 2 gliomas are incurable by surgery and complementary treatments are vital to improving prognosis. This guideline provides recommendations on the multidisciplinary treatment of grade 2 astrocytomas and oligodendrogliomas based on the best evidence available.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11467015 | PMC |
| http://dx.doi.org/10.1007/s12094-024-03456-x | DOI Listing |
Publication Analysis
Top Keywords
grade gliomas
12
seom-geino clinical
4
clinical guidelines
4
grade
4
guidelines grade
4
gliomas 2023
4
2023 2021
4
2021 health
4
health organization
4
organization classification
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!